Sign Up to like & get recommendations! 0
Published in 2020 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2020.4414
Abstract: Importance In patients with mechanical valves in the aortic and mitral positions, percutaneous access to the left ventricle (LV) via a transfemoral approach for catheter ablation of ventricular tachycardia (VT) has been considered infeasible. Objective… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Clinical Cardiology"
DOI: 10.1002/clc.22773
Abstract: Ventricular tachycardia (VT) recurrence after catheter ablation for electrical storm is commonly seen in patients with ischemic cardiomyopathy (ICM). read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Clinical Cardiology"
DOI: 10.1002/clc.22918
Abstract: Patients with atrial fibrillation (AF) are at an approximately 0.5% to 3% increased risk of thromboembolism during and immediately after catheter ablation. Treatment guidelines recommend periprocedural oral anticoagulation plus unfractionated heparin during ablation. Rivaroxaban and… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Clinical Cardiology"
DOI: 10.1002/clc.23753
Abstract: Previous studies that evaluated the influence of anxiety on recurrence of atrial fibrillation (AF) after catheter ablation showed inconsistent results. We performed a meta‐analysis of cohort study to systematically evaluate the association between anxiety and… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Clinical Cardiology"
DOI: 10.1002/clc.23806
Abstract: The antral region of pulmonary veins (PV)s seems to play a key role in a strategy aimed at preventing atrial fibrillation (AF) recurrence. Particularly, low‐voltage activity in tissue such as the PV antra and residual… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Clinical Cardiology"
DOI: 10.1002/clc.23841
Abstract: Catheter ablation (CA) is an effective treatment for patients with atrial fibrillation (AF). The potential of CA to benefit AF patients with heart failure and preserved ejection fraction (HFpEF) is uncertain. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Clinical Cardiology"
DOI: 10.1002/clc.23949
Abstract: Although catheter ablation (CA) has become a standard therapeutic approach to atrial fibrillation (AF), it imposes a low but relevant risk of thromboembolic complications of around 0.5%–1%, including ischemic strokes, and has an additional risk… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Clinical Cardiology"
DOI: 10.1002/clc.23975
Abstract: Increasing evidence has shown the relationship between sleep and the recurrence of atrial fibrillation (AF). However, the association of different sleep patterns with AF recurrence after catheter ablation was rarely studied. We aimed to assess… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Clinical cardiology"
DOI: 10.1002/clc.24036
Abstract: BACKGROUND Evidence on outcomes of catheter ablation (CA) for atrial fibrillation (AF) in patients with autoimmune disease (AD) is limited. HYPOTHESIS Patients with AD had worse outcomes after CA procedures for AF. METHODS A retrospective… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2604
Abstract: To investigate the association between catheter ablation for atrial fibrillation (AF) and mortality as well as hospitalization for heart failure (HF) in patients with HF across the ejection fraction (EF) spectrum. read more here.